GUÍAS ALAD People with Type 2 diabetes now have personalized treatment options Genetic factors tied to obesity may protect against diabetes. OPS. Guias ALAD de diagnostico, control y tratamiento de la Diabetes Mellitus Tipo 2, (In Spanish) Veracruz Initiative for Diabetes Awareness, Barcelo A, Jawed M, Qiang A. PAHO Diabetes Guideline Project Group. .. Guías ALAD sobre el diagnóstico, control y tratamiento de la diabetes .. Guía clínica de diabetes tipo 2. Santiago: MINSAL;. Available from:

Author: Shakagrel Gagal
Country: Turks & Caicos Islands
Language: English (Spanish)
Genre: Literature
Published (Last): 18 July 2018
Pages: 75
PDF File Size: 16.19 Mb
ePub File Size: 14.57 Mb
ISBN: 365-4-98985-446-1
Downloads: 85739
Price: Free* [*Free Regsitration Required]
Uploader: Vuk

PAHO WHO | Diabetes | Scientific and Technical Material

Diabetes Obes Metab ; Genital and urinary tract infections in diabetes: Treatment maintenance duration of dual therapy with metformin and sitagliptin in type 2 diabetes. Am J Med ; Am J Clin Nutr, Med Sci Sports Exerc. Changes in lifestyle are associated with mass migration from the rural areas to the urban areas Cochrane Database Syst Rev, Diabetes Rev6: Cost-effectiveness of insulin analogues for diabetes mellitus, CMAJ ; 4: Medical management of hyperglycemia in type 2 diabetes: Diabetes mellitus is a group of diseases characterized by an elevated blood glucose level hyperglycaemia resulting from defects in insulin secretion, in insulin action, or both.

Managed care perspective on three new agents for type 2 diabetes. Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients.


Diabetes Care ; Revista de la ALAD ; 3: Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes.

Safety and tolerability of sitagliptin in clinical studies: Br J Nutr diabetrs 83 Suppl 1: Nissen S, Wolski N. Am J Health-Syst Pharm. Sodium-glucose cotransporter-2 inhibition and the potential for renal protection in diabetic nephropathy. A randomized trial of insulin aspart versus human insulin in pregnant women. The incidence of mild and severe hypoglycaemia in patients with type 2 diabetes mellitus treated with sulfonylureas: Majewski C, Bakris GL.

Long-term study of patients with type 2 diabetes and moderate renal impairment shows that dapagliflozin reduces weight and blood pressure but does not improve glycemic control.

American Diabetes Association®

Lixisenatide in patients with type 2 diabetes and acute coronary syndrome. Disproportionately elevated proinsulin in Pima Indians with noninsulin-dependent diabetes mellitus.

Metformin prevents weight gain by reducing dietary intake during insulin therapy in patients with type 2 diabetes mellitus. Efficacy and safety of treatment with sitagliptin or glimepiride in patients with type 2 diabetes inadequately controlled on metformin monotherapy: Segunda Encuesta Nacional de Factores de Riesgo.

Effects of SGLT2 inhibitors on cardiovascular outcomes. A Framework for Comprehensive Diabetes Care Diabetes management is complex and requires training and resources. Use of a claims-based active drug safety surveillance system to assess the risk of 20100 pancreatitis with exenatide or sitagliptin compared to metformin or glyburide.

Dapagliflozin in patients with type 2 diabetes receiving high doses of insulin: Dapagliflozin monotherapy in type 2 diabetic patients with inadequate glycemic control by diet and exercise: Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: Kidney Int ; Bailey C, Turner R.


Population and Individual Approach to wlad Prevention and Management of Diabetes and Obesity, Obesity and diabetes guizs affecting the peoples of the Americas at high and increasing rates. Am J Clin Nutr, Richter B, Bandeira-Echtler E, et al.

Diabetes: Scientific and Technical Material

Prevalence of diabetes, obesity, hypertension and hyperlipidemia in the central area of Yuias. A week, randomized, parallel, treat-to-target trial comparing insulin detemir with NPH insulin as add-on therapy to oral glucose-lowering drugs in insulin-naive people with type 2 diabetes.

Unless appropriate action is taken, it is predicted that there will be at least million people in the world with type 2 diabetes by the year Am J Clin Nutr ; 67 Suppl 1: Building Blocks in Diabetes Education and Control: Clinical practice guidelines for treatment of diabetes mellitus.

Standards of Medical Care in Diabetes Diabetes Metab ; N Engl J Med ;

Subscribe US Now